Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health

A coalition of civil society organisations is calling on the Polish government to support the classification of Resorcinol as a substance of very high concern (SVHC) under the REACH regulation. The organisations argue that Resorcinol is a known endocrine disruptor that inhibits thyroperoxidase (TPO), affecting thyroid hormone levels essential for prenatal brain development. They highlight that the substance is a high-volume compound used in cosmetics, pharmaceuticals, and rubber products, posing risks to workers and the public. The letter asserts that Resorcinol meets the 'equivalent level of concern' (ELoC) criteria due to the irreversible nature of its developmental effects, such as hypothyroidism and neurological impacts in children.

• Resorcinol is identified as an endocrine disruptor that inhibits thyroperoxidase (TPO), an enzyme critical for thyroid hormone synthesis, which is essential for brain development in unborn children.
• Exposure to Resorcinol is linked to severe and potentially irreversible developmental effects in humans, including goiter, hypothyroidism, and neurological impacts in children.
• Resorcinol is a high-volume compound, registered at 1,000-10,000 tons per year, and is used in a wide range of applications including cosmetics, hygiene products, pharmaceuticals, flame retardants, adhesives, resins, and rubber products.
• The authors argue that Resorcinol meets the 'equivalent level of concern' (ELoC) criteria under REACH article 57(f) because its effects on prenatal brain development are serious and cannot be easily treated or reversed.

APA

Jensen, G. K. (2021). Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health. ClientEarth. https://www.clientearth.org/media/nhfmsrzx/resorc_4.pdf

Chicago

Jensen, Genon K. Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health. ClientEarth, 2021. https://www.clientearth.org/media/nhfmsrzx/resorc_4.pdf.

Wikipedia

{{cite press release |last1=Jensen |first1=Genon K. |title=Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health |publisher=ClientEarth |date=6 September 2021 |url=https://www.clientearth.org/media/nhfmsrzx/resorc_4.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@misc{jensen2021resorcinol, author = {Jensen, Genon K.}, title = {{Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health}}, publisher = {ClientEarth}, year = {2021}, month = sep, url = {https://www.clientearth.org/media/nhfmsrzx/resorc_4.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }